Peer-reviewed veterinary case report
Cat with liver neuroendocrine tumor causing weight loss and drooling
By Ferreira-Neves, Patricia et al.·Published in Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·2008·Ecole Nationale Vé, France·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Immunohistochemical characterization of a hepatic neuroendocrine carcinoma in a cat.
- Species:
- cat
Plain-English summary
A 5-year-old female mixed-breed cat was found to have a liver mass after showing signs of severe weight loss, drooling, and persistent nasal discharge. Sadly, the cat died suddenly, and a necropsy revealed a large, firm tumor in the liver. The tumor was identified as a hepatic neuroendocrine carcinoma, which is a rare type of cancer. Unfortunately, due to the advanced nature of the disease at the time of diagnosis, there was no treatment that could save the cat.
People also search for: cat liver cancer symptoms · why is my cat losing weight · cat drooling and nasal discharge
Abstract
A hepatic mass was identified in a 5-year-old, female mixed-breed cat that died spontaneously after a clinical history of progressive emaciation, ptyalism, and persistent coryza. At necropsy, a 7-cm-diameter, yellow-brown, firm, multilobulated tumor was identified in the liver. Microscopically, the mass consisted of neoplastic cells arranged in small, closely packed nests within a thin fibrovascular stroma. These cells were of medium sized and polygonal, with fine argyrophilic cytoplasmic granules. Nuclei were predominantly round with finely stippled chromatin and indistinct nucleoli. Mitotic figures were numerous. Immunohistochemically, most of the neoplastic cells were immunoreactive for chromogranin A, neuron-specific enolase (NSE), and cytokeratin AE1/AE3 and weakly labeled for synaptophysin. The tumor was negative for glial fibrillary acidic protein (GFAP), vimentin, and cytokeratins 5, 6, 8, and 17. Vascular emboli and intrahepatic micrometastasis were also identified with chromogranin A. All these features were consistent with a hepatic neuroendocrine carcinoma and emphasized the importance of using a panel of antibodies to diagnose such rare tumors.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/18182524/